Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations

J. Bradley Oldemeyer, Richard J. Lund, Matt Koch, A. John Meares, Robert W. Dunlay

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.

Original languageEnglish
Pages (from-to)127-128
Number of pages2
JournalCardiology
Volume94
Issue number2
DOIs
StatePublished - 2000

Fingerprint

Fibric Acids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Rhabdomyolysis
Acute Kidney Injury
Gemfibrozil
Fenofibrate
Pravastatin
Simvastatin
Hyperlipidemias
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations. / Oldemeyer, J. Bradley; Lund, Richard J.; Koch, Matt; Meares, A. John; Dunlay, Robert W.

In: Cardiology, Vol. 94, No. 2, 2000, p. 127-128.

Research output: Contribution to journalArticle

Oldemeyer, J. Bradley ; Lund, Richard J. ; Koch, Matt ; Meares, A. John ; Dunlay, Robert W. / Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations. In: Cardiology. 2000 ; Vol. 94, No. 2. pp. 127-128.
@article{715acf8f6293496089d1e0413864bcb6,
title = "Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations",
abstract = "Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.",
author = "Oldemeyer, {J. Bradley} and Lund, {Richard J.} and Matt Koch and Meares, {A. John} and Dunlay, {Robert W.}",
year = "2000",
doi = "10.1159/000047304",
language = "English",
volume = "94",
pages = "127--128",
journal = "Cardiology",
issn = "0008-6312",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations

AU - Oldemeyer, J. Bradley

AU - Lund, Richard J.

AU - Koch, Matt

AU - Meares, A. John

AU - Dunlay, Robert W.

PY - 2000

Y1 - 2000

N2 - Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.

AB - Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.

UR - http://www.scopus.com/inward/record.url?scp=0034487393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034487393&partnerID=8YFLogxK

U2 - 10.1159/000047304

DO - 10.1159/000047304

M3 - Article

VL - 94

SP - 127

EP - 128

JO - Cardiology

JF - Cardiology

SN - 0008-6312

IS - 2

ER -